Acronym for "chemiluminescence immunoassay". CLIA describes an immunological detection method for proteins, mediators, drugs by means of a chemiluminescence method.
Principle of the test: The determination is carried out by competitive binding of the unknown antigen to mono- or polyclonal specific antibodies after appropriate separation steps.
The measured activity is the higher the more antibodies are bound to the allergen in the first step of the analysis procedure.